Immunitybio Inc (IBRX)

Operating Income Growth

13.45%

Quarterly · Period ending:

IBRX logo

IBRX Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported13.45%
IBRX Quarterly Operating Income YoY % (59.54% → 13.45%)
High-resolution chart · PNG

IBRX operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc Operating Income Growth — Quarterly
Period endingOperating Income Growth
13.4502%
-8.3223%
6.7968%
30.6817%
28.2363%
32.3196%
18.7249%
-0.146%
-16.6633%
14.6836%
-1.3892%
11.7484%
-6.9365%
-16.2631%
-6.2379%
-15.1809%
7.315%
-11.2538%
-156.6665%
-19.6715%
-68.721%
-135.039%
-49.9393%
-322.9391%
-205.2518%
-104.8331%
-18.9113%
34.0391%
39.8897%
35.1032%
29.6528%
0.2577%
-18.4741%
-12.3454%
-1.1294%
25.8302%
31.5646%
20.1897%
68.4271%
25.1565%
59.5358%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.